ODYYOTCSurgical & Medical Instruments & ApparatusFiscal year ends July 31
Odyssey Health, Inc.
Financials through Q3 FY2026, quarter ended Apr 30, 2026Last filing: 10-Q on Jun 12, 2026
$0.01−0.00 (-16.25%)
Close on Oct 19, 2026
- Market cap
- $1.25M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.0980 (−93.60%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Apr 30, 2026
Valuation
- Market cap
- $1.25M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$3.57M
- EPS, diluted
- -$0.02
- Book value per share
- -$0.05
- Diluted shares
- 187M
Twelve years at a glance
Fiscal years 2014 to 2025 and trailing twelve months, USD
Revenue
–
Gross profit
–
Operating income
-$938.36K
Net income
-$3.57M
EPS, diluted
-$0.02
Free cash flow
–
Reported periodTrailing twelve months